MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 17, 2007; DOI: 10.1124/mol.107.037747


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.037747v1
72/2/429    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Xiang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Xiang, Y.


Received for publication May 3, 2007.
Revised May 16, 2007.
Accepted for publication May 16, 2007.

NSF Regulates {beta}2 Adrenoceptors Trafficking and Signaling in Cardiomyocytes

Yongyu Wang 1, Benjamin Lauffer 2, Mark Von Zastrow 2, Brian Kobilka 3, Yang Xiang 1*

1 University of Illinois at Urbana Champaign 2 University of California at San Francisco 3 Stanford University

* Address correspondence to: E-mail: kevinyx{at}life.uiuc.edu

Abstract

Recycling of G protein-coupled receptors (GPCRs) determines the functional resensitization of receptors and is implicated in switching {beta}2 adrenoceptor ({beta}2AR) G protein specificity in cardiomyocytes. The human {beta}2AR carboxyl end binds to the N-ethylmaleimide-sensitive factor (NSF), an ATPase integral to membrane trafficking machinery. Interestingly, the human {beta}2AR (h{beta}2AR) carboxyl end pulled down NSF from mouse heart lysates whereas the murine one did not. Despite this difference, both {beta}2ARs exhibited substantial agonist-induced internalization, recycling, and Gi coupling in cardiomyocytes. The h{beta}2AR, however, displayed faster rates of agonist-induced internalization and recycling when compared to the m{beta}2AR; and a more profound Gi component in its contraction response. Replacing the m{beta}2AR proline (-1) with a leucine generated a gain-of-function mutation, m{beta}2AR-P417L, with a rescued ability to bind NSF, faster internalization and recycling than the m{beta}2AR, and a significant enhancement in Gi signaling, which mimics the h{beta}2AR. Selective disruption of the m{beta}2AR-P417L binding to NSF inhibited the receptor coupling to Gi. Meanwhile, inhibiting NSF with N-ethylmaleimide blocked the m{beta}2AR recycling following agonist-induced endocytosis. Expressing the NSF E329Q mutant lacking ATPase activity inhibited the m{beta}2AR coupling to Gi in cardiomyocytes. Our results revealed a dual regulation on h{beta}2AR trafficking and signaling by NSF through direct binding to cargo receptor and its ATPase activity, and uncovered an unprecedented role for the receptor binding to NSF in regulating G protein specificity that has diverged between mouse and human {beta}2ARs.


Key words: Adrenergic, Gi family, Gs family, G protein regulation, Desensitization/uncoupling, Sequestration/Internalization, Recycling


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes
J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics